Trial Profile
Phase I/II trial of Tr1 lymphocytes [OvaSave; TxCell] in patients with ulcerative colitis.
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 22 Mar 2011
Price :
$35
*
At a glance
- Drugs Regulatory T lymphocyte cell therapy-OvaSave (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors TxCell
- 22 Mar 2011 New trial record